WuXi Advanced Therapies Capacity Update July 2024: Cell & Gene Therapy

In this presentation from the July 2024 OPCU event, WuXi Advanced Therapies provides an update on the capacity available at its 400,000+ square foot campus in Philadelphia, PA. Capabilities include everything from early discovery services, to process development and scale-up, IND-enabling studies, clinical production, and commercial scale manufacturing. This unique CTDMO not only provides development and manufacturing services to cell and gene therapy providers, but also offers co-located bioanalytical testing services, thus streamlining timelines and de-risking products with complex and/or time sensitive lot release. During this session you will learn how the expert and experienced team in Philadelphia supports cell therapy and viral vector production across a variety of modalities and stages of clinical and commercial manufacturing.